Baker, Daniel
Baker, Daniel was paid $1.01M by Medicaid between Jul 2019 and Dec 2024, across 27 billing codes. Its largest line is 94729, — 22% of everything it billed.
33Billing provider infoBAKER, DANIEL
SAN ANTONIO, TX 78201
SAN ANTONIO, TX 78201
33aNPI1306244496assigned 12/05/2014
33bProvider typeCertified Respiratory Therapist
28Total paid$1.01M
24GClaims53,808
24DCodes billed27
24AFirst – last monthJul 2019 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,074 | $27K | |
| 2020 | 1,263 | $25K | |
| 2021 | 21,612 | $438K | |
| 2022 | 15,178 | $258K | |
| 2023 | 10,266 | $191K | |
| 2024incomplete | 4,415 | $67K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 94729 | 22% | 6,043 | 4,961 | $225K | |
| 94726 | 18% | 5,933 | 5,063 | $182K | |
| 94060 | 16% | 5,972 | 5,093 | $160K | |
| 94618 | 11% | 5,781 | 4,926 | $107K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.1% | 2,346 | 1,720 | $71K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6.1% | 2,032 | 1,437 | $61K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.5% | 3,157 | 2,465 | $56K |
| 94644 | 5.2% | 1,421 | 1,027 | $52K | |
| 94200 | 3.3% | 5,977 | 5,030 | $33K | |
| 94645 | 1.7% | 1,422 | 1,029 | $17K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.7% | 2,087 | 1,436 | $17K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,773 | 2,599 | $10K |
15 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 449 | $6K |
| 94727 | <1% | 179 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 227 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,425 | $303.81 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 18 | $223.25 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 13 | $37.64 |
| 94761 | <1% | 299 | $13.88 | |
| 94664 | 0% | 6,112 | $0.00 | |
| A7038 | Filter, disposable, used with positive airway pressure device | 0% | 13 | $0.00 |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | 0% | 27 | $0.00 |
| A4617 | Mouth piece | 0% | 14 | $0.00 |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 14 | $0.00 |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | 0% | 30 | $0.00 |
| A7013 | Filter, disposable, used with aerosol compressor or ultrasonic generator | 0% | 14 | $0.00 |
| S8101 | Holding chamber or spacer for use with an inhaler or nebulizer; with mask | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.